March 2012
Volume 53, Issue 14
ARVO Annual Meeting Abstract  |   March 2012
Genome-Wide Expression Profiling in the Retina of Vldlr Knockout Mouse
Author Affiliations & Notes
  • Svetlana V. Kiosseva
    Ophthalmology, Dean A McGee Eye Inst, Univ of OK, Oklahoma City, Oklahoma
  • Lily L. Wong
    Ophthalmology, Dean A McGee Eye Inst, Univ of OK, Oklahoma City, Oklahoma
  • Xiaohong Zhou
    Massachusetts Eye and Ear Infirmary Howe Lab, Harvard Med School, Boston, Massachusetts
  • James F. McGinnis
    Ophthalmology, Dean A McGee Eye Inst, Univ of OK, Oklahoma City, Oklahoma
  • Footnotes
    Commercial Relationships  Svetlana V. Kiosseva, None; Lily L. Wong, None; Xiaohong Zhou, None; James F. McGinnis, None
  • Footnotes
    Support  NIH: P30-EY12190, COBRE-P20 RR017703, R21EY018306, R01EY018724. FFB C-NP-0707-0404-UOK08. NSF:CBET-0708172. Unrestricted funds from PHF and RPB and an RPB SSI award to JFM.
Investigative Ophthalmology & Visual Science March 2012, Vol.53, 1142. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Svetlana V. Kiosseva, Lily L. Wong, Xiaohong Zhou, James F. McGinnis; Genome-Wide Expression Profiling in the Retina of Vldlr Knockout Mouse. Invest. Ophthalmol. Vis. Sci. 2012;53(14):1142.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : To identify candidate genes and pathways that are involved in the pathophisiology of Age related Macular Degeneration (AMD) by microarray analysis of the retinas of Very low density lipoprotein receptor (Vldlr-/-) knockout mouse, an animal model for a form of AMD called Retinal Angiomatous Proliferation (RAP). We focused on characterization of the early events of retinal defects at postnatal day (P)14 when subretinal neovascularization begins and in the newly matured (P28) retina.

Methods: : Labeled and amplified cRNAs from wild type (WT) and Vldlr-/- mice on a C57/BL6J background were hybridized to Illumina’s Sentrix Mouse-6 Expression BeadChip arrays containing~47,000 transcripts. Gene expression from scanned images was quantified, analyzed and shown as fold change when comparing Vldlr-/- to WT mouse retinas. Genes that changed by 1.8 fold and pFDR<0.05 were subsequently analyzed. Ingenuity Pathway Analysis (IPA) was used to search for biological processes, pathways and networks. The expression of several genes with notable fold change values was confirmed by qRT-PCR and differential protein expression by Western blots.

Results: : Two hundred eleven genes (P14) and 229 genes (P28) were differentially expressed in Vldlr-/- retina. Sixty six genes (P14) and 80 genes (P28) were up-regulated, and 145 (P14) and 140 (P28) genes were down-regulated, respectively. The top up-regulated genes were Serpina3n and Gdpd3 at P14, Serpina3n and Edn2 at P28, and down-regulated genes were Guca1b and Tomm22 at P14, Tomm22 and Mns1 at P28. Fourteen up-regulated genes were common to two point times including Gdpd3, Rgs5, Serpina3n, Crym, Tomm22, and 40 common genes were down-regulated (Guca1b, Pde6c, Myo7, Picalm, Ccl21b). The differentially expressed genes included those involved in developmental and genetic disorders, ophthalmic, neurological and metabolic diseases. The top canonical pathways for up-regulated genes were intrinsic prothrombin activation and cell cycle checkpoint control (P14), acute phase response and oncostatin M signaling (P28), while the phototransduction pathway was the top canonical pathway for the down-regulated genes.

Conclusions: : This study demonstrates novel genome-wide transcriptional profiling data of retinal development in a mouse model of AMD and further provide new insights into the molecular pathways and networks that can be targets for new therapeutics.

Keywords: gene microarray • retina • age-related macular degeneration 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.